©The Author(s) 2021.
World J Cardiol. Jan 26, 2021; 13(1): 11-20
Published online Jan 26, 2021. doi: 10.4330/wjc.v13.i1.11
Published online Jan 26, 2021. doi: 10.4330/wjc.v13.i1.11
Table 2 Infective organisms identified in primary hospitalizations for native valve infective endocarditis by diabetes mellitus in the United States from 2004–2014
| Infective organisms | NVIE | ||
| No DM (%) | DM (%) | P value | |
| Staphylococcus aureus | 33.1 | 35.6 | < 0.001 |
| Other staphylococcus | 5.4 | 6.7 | < 0.001 |
| Viridans streptococci | 18.6 | 15.5 | < 0.001 |
| Enterococci | 6.5 | 7.6 | < 0.001 |
| Pneumococcus | 0.5 | 0.4 | 0.11 |
| Group A streptococci | 0.7 | 0.5 | 0.003 |
| Group B streptococci | 1.3 | 1.6 | < 0.001 |
| Group C streptococci | 0.1 | 0.1 | 0.44 |
| Group G streptococci | 0.2 | 0.2 | 0.87 |
| Gram negative | 3.8 | 4.8 | < 0.001 |
| Anaerobes | 0.4 | 0.3 | 0.82 |
| Fungemia | 0.2 | 0.2 | 0.81 |
- Citation: Abe T, Eyituoyo HO, De Allie G, Olanipekun T, Effoe VS, Olaosebikan K, Mather P. Clinical outcomes in patients with native valve infective endocarditis and diabetes mellitus. World J Cardiol 2021; 13(1): 11-20
- URL: https://www.wjgnet.com/1949-8462/full/v13/i1/11.htm
- DOI: https://dx.doi.org/10.4330/wjc.v13.i1.11